Australian veterinarians can now purchase our full range of products directly from Zoetis.
Zoetis Direct is a business-to-business initiative. Zoetis does not supply products directly to the general public.
VIDEO: OVERVIEW OF ZOETIS DIRECT
Zoetis Direct evolves the way we deliver value to you, your clinic and importantly to your patients. You will enjoy transparent pricing, a simple ordering system, seamless delivery and easy access to expert advice through our direct distribution commitment.
When it comes to feed supplements cattle have a discerning palate. Bovatec® has been shown to be more palatable then monensin1. This means better consumption of your feed or supplement when you choose Bovatec®. It improves liveweight gains and feed conversion efficiency on pasture while controlling clinical signs of coccidiosis in animals exposed to infection around feeding and watering points. Bovatec® has also been shown to improve the absorption and retention of Phosphous5,6 which is critically deficient in many Australian forage systems.
The cost of coccidiosis
Calves are particularly vulnerable to the disease coccidiosis. Caused by the protozoans Eimeria zuernii or Eimeria bovis, coccidiosis can impair performance and prevent calves from weaning at their optimum age and weight. If left untreated it can escalate from watery faeces and reduced growth to bloody scours and even death.
Cattle prefer Bovatec®
The application of lasalocid (Bovatec®) to grazing cattle that are hand fed or have access to free-choice supplements have been intensively investigated and summarised (FDA 2001).
In 15 field studies when Bovatec® is incorporated in the grain supplement to slaughter, stocker (backgrounded), or feeder cattle between 60 and 200 mg/hd/day, the cattle had significant (P<0.05) improvement in gain over the cattle fed the grain supplement without Bovatec®.
FDA 2001 - Efficacy of Bovatec® in hand fed supplements for pasture cattle
Bovatec® (Iasalocid Dose) (Mg/head/day)
Treatment Mean of ADG (kg/d)
Improvement over control
Avcare Literature Review. The role of enteric antibiotics in livestock production, May 2003.
Bovatec® does not impact feed intake as much as monensin1. Brazle and Kuhl (1986)2 confirmed Bovatec® is more palatable than Rumensin®. This makes Bovatec® the preferred ionophore for free-choice, mineral-based supplement systems2.
Average Daily Gain
Bovatec® The Heavy Hitter
Improves liveweight gains and feed conversion efficiency in growing cattle and lot fed beef cattle
Controls clinical signs of coccidiosis and the reduction of faecal shedding caused by Eimeria bovis and Eimeria zuernii in growing cattle
NOTE: Refer to product label for registered label claims.
1. The effect of ionophores on feed intake by feedlot cattle, 1995, Gary Vogel, Lilly Research Laboratories, Canyon Texas.
2. Brazle. F, Kuhl, G. 1986, Bovatec vs. Rumensin fed in free-choice mineral-grain mixtures on early intensive grazed, native grass. Cattlemen's Day, Kansas State University, Manhattan, KS. March 1986.
3. Steven W. Page, Avcare Limited 2003. The role of enteric antibiotics in livestock production, a review of published literature.
4. J. F. Hentges, Jr and W. E. Kunkle. Stability of Lasalocid in standard and blackstrap molasses with and without a suspending agent, 1984 Florida Beef Report, Pg 81-82.
Rumensin® is a registered trademark of Eli Lilly and Company. Bovatec® is a registered trademark.
5. Starnes, SR: et. al. (1984) Influence of monensin and Lasalocid on mineral metabolism and ruminal urease activity in steers. J Nutr 114: 518-525.
6. Duff GC: et. al. (1994) Effects of Lasalocid and monensin plus tylosin on serum metabolic hormone and clinical chemistry profiles of beer steers fed a 90% concentrate diet. J Animal Sci 72:4, 1049-1058